Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study. [electronic resource]
Producer: 20160815Description: 1198-201 p. digitalISSN:- 1463-1326
- Combined Modality Therapy -- adverse effects
- Diabetes Mellitus, Type 2 -- blood
- Diet, Diabetic
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Resistance
- Drug Therapy, Combination -- adverse effects
- Exercise
- Glycated Hemoglobin -- analysis
- Humans
- Hyperglycemia -- prevention & control
- Hypoglycemic Agents -- administration & dosage
- Japan
- Pioglitazone
- Piperidines -- adverse effects
- Thiazolidinediones -- administration & dosage
- Uracil -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.